Laboratory biomarkers for lung disease severity and progression in cystic fibrosis
Open Access
- 16 May 2020
- journal article
- review article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 508, 277-286
- https://doi.org/10.1016/j.cca.2020.05.015
Abstract
No abstract availableKeywords
Funding Information
- University of Debrecen (GINOP-2, K109076, IP00064203, 00/24022, /0001634, LM2018132, SRC 013, ERARE15, -010/JTC 2015)
- eu (H2020-SC1-2017-755021)
This publication has 115 references indexed in Scilit:
- Changes in transcriptome of native nasal epithelium expressing F508del-CFTR and intersecting data from comparable studiesRespiratory Research, 2013
- BPI-ANCA and Long-Term Prognosis among 46 Adult CF Patients: A Prospective 10-Year Follow-Up StudyJournal of Immunology Research, 2012
- The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosisBMC Pulmonary Medicine, 2012
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationThe New England Journal of Medicine, 2011
- The Chitinase-Like Protein YKL-40 Modulates Cystic Fibrosis Lung DiseasePLOS ONE, 2011
- Elevated miR-155 Promotes Inflammation in Cystic Fibrosis by Driving Hyperexpression of Interleukin-8Online Journal of Public Health Informatics, 2011
- Plasma TGF‐β1 in pediatric cystic fibrosis: Potential biomarker of lung disease and response to therapyPediatric Pulmonology, 2011
- Impact of Pseudomonas and Staphylococcus Infection on Inflammation and Clinical Status in Young Children with Cystic FibrosisThe Journal of Pediatrics, 2009
- Elafin, an Elastase-specific Inhibitor, Is Cleaved by Its Cognate Enzyme Neutrophil Elastase in Sputum from Individuals with Cystic FibrosisOnline Journal of Public Health Informatics, 2008
- Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2008